Markets:

Overview

News

Currencies

International

Treasuries

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

3.040 +0.140 (+4.83%)

Streaming Delayed Price Updated: 4:00 PM EST, Nov 25, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Cassava Sciences, Inc. - Common Stock

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

38 39 Next >

Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday ↗

October 17, 2023

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Topics Stocks

Cassava Sciences Inc. (NASDAQ: SAVA) Leading the Way in Tuesday Trading Based on Percentage Gain

October 17, 2023

Via Investor Brand Network

Why Is SciSparc (SPRC) Stock Up 105% Today? ↗

October 17, 2023

SciSparc stock is rising higher on Tuesday as shares of SPRC regain compliance with the Nasdaq minimum bid listing requirement.

Via InvestorPlace

SAVA Stock Continues to Plunge on Misconduct Allegations ↗

October 16, 2023

An investigation into one of Cassava Sciences' advisors is pushing shares down. Here's why investors should worry about SAVA stock.

Via InvestorPlace

Why Cassava Sciences Stock Is Tanking Today ↗

October 13, 2023

Investors are worried about a leaked report related to alleged data manipulation for Cassava's Alzheimer's disease treatment candidate.

Via The Motley Fool

Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

October 13, 2023

Gainers Sigma Additive Solutions, Inc. (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.

Via Benzinga

SAVA Stock Alert: Cassava Sciences Addresses Leaked Report ↗

October 13, 2023

SAVA stock is falling hard following the publication of a City University of New York report by Science regarding Hoau-Yan Wang.

Via InvestorPlace

UK Authority Approves Microsoft's $69B Activision Blizzard Acquisition, Google Search Gets Generative AI Boost, Big Banks Earnings: Today's Top Stories ↗

October 13, 2023

Benzinga

Via Benzinga

Topics Artificial Intelligence

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

October 13, 2023

Via Benzinga

Alzheimer's-Focused Cassava Sciences Faces Controversy as Key Collaborator Accused of Scientific Misconduct ↗

October 13, 2023

Cassava Sciences Inc (NASDAQ: SAVA), the Alzheimer-focused firm, is facing further controversy as a recent investigation by the City University of New York (CUNY) has implicated neuroscientist Hoau-Yan...

Via Benzinga

Why Comtech Telecommunications Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket ↗

October 13, 2023

Gainers Oblong, Inc. (NASDAQ: OBLG) shares rose 295.7% to $1.16 in pre-market trading.

Via Benzinga

Outset Medical, SMART Global And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

October 13, 2023

U.S. stock futures traded lower this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Statement by Cassava Sciences Regarding an Internal CUNY Report Leaked to the Press

October 12, 2023

From Cassava Sciences, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

October 12, 2023

Via Benzinga

Why Shares of Cassava Sciences Soared This Week ↗

October 06, 2023

Cassava bounced back from hitting a 52-week low to start the week.

Via The Motley Fool

Cassava Sciences to Present at the Jefferies Biotech CNS/Neuro Summit in NY

October 05, 2023

CEO to Present on Wednesday, October 11th, at 10:30am ET

From Cassava Sciences, Inc.

Via GlobeNewswire

Stocks That Hit 52-Week Lows On Monday ↗

October 02, 2023

On Monday, 369 companies set new 52-week lows.

Via Benzinga

Cassava Sciences Completes Patient Enrollment for Pivotal Phase 3 Clinical Trial of Oral Simufilam in Alzheimer’s Disease

October 02, 2023

From Cassava Sciences, Inc.

Via GlobeNewswire

Cassava Sciences Announces Positive Interim Safety Review of Simufilam On-going Phase 3 Trials in Patients with Alzheimer’s Disease

September 18, 2023

From Cassava Sciences, Inc.

Via GlobeNewswire

The 7 Best Meme Stocks to Buy Now: September 2023 ↗

September 14, 2023

Consider these seven past and present faves of the Reddit set to be the best meme stocks to buy this month.

Via InvestorPlace

Jim Cramer Says No To This Fintech Titan With Declining Margins: 'I Think It's A Value Trap' ↗

September 12, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said ONEOK, Inc's (NYSE: OKE) management is terrific. "The CFO Walter Hulse is like you and me, a Jersey-ite.

Via Benzinga

Cassava Sciences Announces Science Publication That Confirms Mechanism of Action of Simufilam, a Novel Drug Candidate for People with Alzheimer’s Disease

September 11, 2023

From Cassava Sciences, Inc.

Via GlobeNewswire

Cassava Sciences Invited to Present in Four Upcoming Investor Conferences

September 06, 2023

From Cassava Sciences, Inc.

Via GlobeNewswire

Snowflake (SNOW) Stock Is Sliding Despite AI Hopes ↗

August 24, 2023

Snowflake (SNOW) stock is on the move Thursday following the release of the company's second-quarter earnings report for fiscal 2024.

Via InvestorPlace

Topics Artificial Intelligence

Is Splunk (SPLK) Stock the Next AI Giant? ↗

August 24, 2023

Splunk (SPLK) stock climbed higher on Thursday as investors weighed the company's value in the AI market following its earnings report.

Via InvestorPlace

Topics Artificial Intelligence

Insider Richard Barry Just Doubled Down on Cassava (SAVA) Stock ↗

August 24, 2023

Cassava had $168.4 million of cash at the end of June after losing $28.7 million during the second quarter of 2023. SAVA stock is up 5%

Via InvestorPlace

10 Health Care Stocks With Whale Alerts In Today's Session ↗

August 14, 2023

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

August 11, 2023

During the Friday's sesion, 157 stocks hit new 52-week lows.

Via Benzinga

Cassava Sciences Reports Q2 2023 Financial Results and Operating Updates

August 03, 2023

From Cassava Sciences, Inc.

Via GlobeNewswire

Why These 3 Stocks Are the Worst Ways to Play Biotech Right Now ↗

July 13, 2023

These three worst biotech stocks are not investable even if you're bullish on the sector overall. There are better options.

Via InvestorPlace

< Previous 1 2

...

9 10 11 12 13 14 15 16 17

...

38 39 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Cassava Sciences, Inc. - Common Stock (NQ:SAVA)

All News about Cassava Sciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today